MINE regimen

chemotherapy protocol consisting of mitoguazone, ifosfamide, vinorelbine, and etoposide; used as salvage chemotherapy for relapsed and refractory Hodgkin's disease

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Experts

1.	Camus, M: 1 article (01/2011)
2.	Guillet, G: 1 article (01/2011)
3.	Hainaut-Wierzbicka, E: 1 article (01/2011)
4.	Levillain, P: 1 article (01/2011)
5.	Lopez, L: 1 article (01/2011)
6.	Saulnier, J-P: 1 article (01/2011)
7.	Akbulut, Hakan: 1 article (09/2010)
8.	Buyukcelik, Abdullah: 1 article (09/2010)
9.	Demirkazik, Ahmet: 1 article (09/2010)
10.	Dincol, Dilek: 1 article (09/2010)

Related Diseases

1.	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/01/2005 - "[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma]." 09/01/2010 - "Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP."
2.	Hodgkin Disease (Hodgkin's Disease) 07/01/1995 - "The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease." 04/01/2001 - "The MINE regimen (mitoguazone, ifosfamide, vinorelbine and etoposide) is a salvage chemotherapy for relapsed and refractory Hodgkin's disease. "
3.	Neoplasms (Cancer) 07/01/1995 - "Given early in the course of progressive HD, the MINE regimen reduced tumor burden in a high proportion of patients with relapsed or refractory disease. "
4.	Erythema 01/01/2011 - "Cutaneous adverse effects of MINE regimen are uncommon and chiefly consist of erythema and oedema of the extremities. "

Related Drugs and Biologics

1.	Ifosfamide
2.	Etoposide (VP 16)
3.	Mesna (Coenzyme M)
4.	Mitoxantrone (Novantrone)
5.	Mitoguazone (MGBG)
6.	Vinorelbine (Navelbine)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)